Health Care

NEOGEN insider trade: Gregory S. buys 1,211 shares, sells 337, and offloads 1,211 RSUs—showing confidence amid a volatile, 52‑week low stock.

NEOGEN insider buying surge: execs buy 1,776 shares amid product pipeline buzz—what it means for investors and stock value.

Insider buying at NEOGEN Corp. signals confidence amid price swings, suggesting the diagnostic firm may be undervalued and poised for a rebound.

Insider sales and buys show NEOGEN’s leadership balancing liquidity with confidence—an insider‑driven hint of possible upside amid a 4.5% weekly dip.

Rallybio CFO buys shares amid merger buzz—insider confidence, $13 ex‑dividend, and a bullish outlook for investors.

Acme United’s insider buys reveal strategic confidence amid a medical expansion and My Medic acquisition, offering investors insight into future growth opportunities.

Insightful Medpace insider trade analysis shows Susan Burwig’s sell‑buy moves are strategic portfolio tweaks, not distress signals, supporting continued bullish momentum.

Veracyte board member Jens Holstein’s Rule 10b5‑1 trades show disciplined, profit‑taking in a bullish market—insider activity that signals portfolio rebalancing, not a loss of confidence.

Insider sales spike at BETA BIONICS as CCO Mark Hopman sells 821 shares—explore what this means for the company’s future and your portfolio.

Dr. Suzanne Topalian’s fresh RSU and option buy signals strong insider confidence in Vir Biotechnology’s virology pipeline and board strategy.